Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154256 · ClinicalTrials.gov registry record · NA
Incentive Disbursement Pattern
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 3,519
- Enrollment target
NCT02154256: Completed NA study, sponsored by University of Pennsylvania.
NCT02154256 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 3,519 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (151% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154256, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,519 participants
- Enrollment target
Study Summary
This study will be a three-arm randomized, controlled trial that the investigators will run in 2014 with approximately 4,000 users of an app called Achievemint. AchieveMint rewards users with points (which can be redeemed for prizes) for every step they take. The investigators will be testing three different point-based programs designed to encourage users to build exercise habits over the course of a month: stable incentives, increasing incentives, and decreasing incentives. After the investigators' month-long intervention period, the investigators will observe users' step counts during a month-long follow-up period to test which of the investigators' habit-building programs leaves users with the best exercise habits (or the highest step counts) after they conclude. The time frame of observation will be 8 months.
Primary Outcome
Subjects will track steps walked with pedometers. The investigators will track how many steps they take for 8 months
Interventions
- BEHAVIORAL Increasing incentives
- BEHAVIORAL Decreasing incentives
- BEHAVIORAL stable incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,519 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT02154256 record still lists
NCT02154256 is an interventional study that assigns participants to a tested intervention. Its 3,519 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (151% higher).
The record links to 0 conditions, and to 3 interventions - of which Increasing incentives is the first listed.
NCT02154256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02154256 about?
NCT02154256 is a clinical study titled "Incentive Disbursement Pattern". This study will be a three-arm randomized, controlled trial that the investigators will run in 2014 with approximately 4,000 users of an app called Achievemint. AchieveMint rewards users with points (which can be redeemed for prizes) for every step they take. The investigators will be testing three ...
What is the current status of trial NCT02154256?
This trial is currently completed. It is a NA study. The enrollment target is 3,519 participants. The study started on 2014-06. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02154256?
The interventions under investigation include: Increasing incentives (BEHAVIORAL), Decreasing incentives (BEHAVIORAL), stable incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT02154256?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02154256's enrollment target sits among peer trials
3,519 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia